NMPA Product

Compound Sulfadiazine Granules

Product approved by National Medical Products Administration (CN)

Basic Information

Product Name

Compound Sulfadiazine Granules

Generic Name

复方磺胺嘧啶颗粒

Strength

磺胺嘧啶0.4g,甲氧苄啶50mg

Dosage Form

颗粒剂

Regulatory Information

Approval Number

国药准字H13023605

Approval StatusApproved

Drug Type

化学药品

Approval Date

March 2, 2021

Company Information

Manufacturer河北凯威制药有限责任公司

Production Company河北凯威制药有限责任公司

Active Ingredients

Compound Sulfadiazine Granules

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy